DUSP4 and neoplasm: In BRAF or RAS mutant tumor cells, DUSP4, DUSP6, SPRY2, and SPRY4 tend to be highly expressed, allowing tumors to evade regular MAPK signaling pathway feedback (Pratilas et al., 2009).